Theravance Biopharma (TBPH) Current Taxes (2014 - 2026)

Theravance Biopharma (TBPH) has 4 years of Current Taxes data on file, last reported at $5.3 million in Q1 2026.

• On a quarterly basis, Current Taxes fell 9.67% year-over-year to $5.3 million in Q1 2026; TTM through Mar 2026 was $5.3 million, a 9.67% decrease from a year earlier, with the FY2025 full-year figure at $5.3 million, down 9.67% from the prior year.
• Current Taxes for Q1 2026 stood at $5.3 million, roughly flat from $5.3 million in the prior quarter.
• Over the last five years, Current Taxes for TBPH reached as high as $26.7 million in Q2 2025 and fell as low as $4.1 million in Q3 2025.
• Historically, Current Taxes has averaged $8.8 million across 3 years, with a median of $5.6 million in 2024.
• On a YoY basis, Current Taxes climbed as much as 9.67% in 2025 and fell as far as 9.67% in 2025.
• Year by year, Current Taxes stood at $5.9 million in 2024, then decreased by 9.67% to $5.3 million in 2025, then changed by 0.0% to $5.3 million in 2026.
• Per Business Quant data, the three most recent Current Taxes figures were $5.3 million in Q1 2026, $5.3 million in Q4 2025, and $4.1 million in Q3 2025.